Ascendis Pharma AS (A71) — Financial Flexibility Index
Ascendis Pharma AS (A71) has a Financial Flexibility Index of -0.01x as of March 2026. Free cash flow of €-7.72 Million (operating CF €-7.72 Million minus capex €0.00) represents 0% of total liabilities (€1.52 Billion). Also explore Ascendis Pharma AS equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascendis Pharma AS Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Ascendis Pharma AS across 10 annual periods. Check A71 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Ascendis Pharma AS (2016–2025)
Year-by-year free cash flow to debt coverage for Ascendis Pharma AS. For the full company profile including market capitalisation, see A71 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | €62.38 Million | €53.90 Million | €1.47 Billion | ▲ +118.0% |
| 2024 | -0.24x | €-304.77 Million | €-306.20 Million | €1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | €-464.92 Million | €-467.36 Million | €971.28 Million | ▲ +17.8% |
| 2022 | -0.58x | €-481.21 Million | €-495.70 Million | €826.39 Million | ▲ +70.2% |
| 2021 | -1.96x | €-393.94 Million | €-417.65 Million | €201.29 Million | ▼ -9.7% |
| 2020 | -1.78x | €-251.69 Million | €-271.55 Million | €141.08 Million | ▲ +16.8% |
| 2019 | -2.14x | €-170.78 Million | €-175.94 Million | €79.62 Million | ▲ +38.7% |
| 2018 | -3.50x | €-136.15 Million | €-138.80 Million | €38.92 Million | ▲ +11.7% |
| 2017 | -3.96x | €-94.16 Million | €-95.10 Million | €23.77 Million | ▲ +10.4% |
| 2016 | -4.42x | €-59.51 Million | €-60.18 Million | €13.46 Million | — |